At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ODD ODDITY Tech Ltd.
Post-Mkt 04-02 19:18:40 EDT
13.86
+0.46
+3.43%
盘后13.83
-0.03-0.22%
18:43 EDT
High13.91Low13.19Vol990.17K
Open13.33D1 Closing13.40Amplitude5.34%
Mkt Cap785.26MTradable Cap542.85MTotal Shares56.66M
T/O13.57MT/O Rate2.53%Tradable Shares39.17M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones
GlobeNewswire  ·  03-30
Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones
Press Release: Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Dow Jones  ·  03-30
Press Release: Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
ODDITY Tech Is Maintained at Neutral by Goldman Sachs
Dow Jones  ·  03-28
ODDITY Tech Is Maintained at Neutral by Goldman Sachs
Oddity Tech Faces Securities Lawsuit After Stock Drops Nearly 50% on Advertising Disruption Disclosure
TIPRANKS  ·  03-26
Oddity Tech Faces Securities Lawsuit After Stock Drops Nearly 50% on Advertising Disruption Disclosure
Oddity Tech director Michael Farello files initial beneficial ownership statement
Reuters  ·  03-25
Oddity Tech director Michael Farello files initial beneficial ownership statement
Key Corporate Announcements Summary for March 24 Evening
Deep News  ·  03-24
Key Corporate Announcements Summary for March 24 Evening
Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients
prnewswire  ·  03-23
Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients
Oddity Tech Director Lilach Payorski Files Initial Beneficial Ownership Statement
Reuters  ·  03-21
Oddity Tech Director Lilach Payorski Files Initial Beneficial Ownership Statement
Oddity Tech Ltd. director Cheresniya Ohad files initial beneficial ownership statement
Reuters  ·  03-21
Oddity Tech Ltd. director Cheresniya Ohad files initial beneficial ownership statement
Oddity Tech Ltd. CTO Niv Price Files Initial Beneficial Ownership Statement
Reuters  ·  03-21
Oddity Tech Ltd. CTO Niv Price Files Initial Beneficial Ownership Statement
Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China
prnewswire  ·  03-19
Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China
ODDITY Tech’s Exchangeable Notes Raise Dilution Risks and May Fuel Short Selling Pressure
TIPRANKS  ·  03-19
ODDITY Tech’s Exchangeable Notes Raise Dilution Risks and May Fuel Short Selling Pressure
Oddity Tech Ltd. files initial beneficial ownership statement for Chief Product Officer Shiran Holtzman-Erel
Reuters  ·  03-19
Oddity Tech Ltd. files initial beneficial ownership statement for Chief Product Officer Shiran Holtzman-Erel
Oddity Tech Ltd. CFO Lindsay Drucker Mann Files Initial Beneficial Ownership Statement
Reuters  ·  03-19
Oddity Tech Ltd. CFO Lindsay Drucker Mann Files Initial Beneficial Ownership Statement
Oddity Tech FY2025 net revenue rose 25.2% to USD 809.84 million
Reuters  ·  03-18
Oddity Tech FY2025 net revenue rose 25.2% to USD 809.84 million
Pomerantz files securities class action against Oddity Tech Ltd. over alleged misleading statements
Reuters  ·  03-18
Pomerantz files securities class action against Oddity Tech Ltd. over alleged misleading statements
Class Action Lawsuit Targets Oddity Tech Over Alleged Securities Law Violations
Reuters  ·  03-17
Class Action Lawsuit Targets Oddity Tech Over Alleged Securities Law Violations
Oddity Tech hit with investor class action after shares drop 49.21%
Reuters  ·  03-16
Oddity Tech hit with investor class action after shares drop 49.21%
Oddity Tech board approves USD 200 million share buyback plan
Reuters  ·  03-12
Oddity Tech board approves USD 200 million share buyback plan
Oddity Tech Announces $200M Share Buyback Plan
THOMSON REUTERS  ·  03-12
Oddity Tech Announces $200M Share Buyback Plan

Introduction

Company Name.
ODDITY Tech Ltd.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Oddity Tech Ltd. operates as a consumer tech company that builds and scales digital-first brands to disrupt beauty and wellness industries. The company serves consumers worldwide through its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. It owns IL MAKIAGE and SpoiledChild brands. The company was incorporated in 2013 and is headquartered in Tel Aviv, Israel with additional office in New York, New York.
Issue price:
--